External Event - 1st to 2nd Mar 2018
The National Institutes of Health (NIH) is convening the 3rd AD Research Summit, to be held on March 1-2, 2018 in Bethesda, Maryland.
The program will build on the foundation laid by the 2012 and 2015 NIH AD Research Summits, and the U.S. National Alzheimer’s Project Act (NAPA)/National Plan to Address AD.
Its central goal is to continue the development of an integrated multidisciplinary research agenda necessary to address critical knowledge gaps and accelerate the discovery and delivery of efficacious treatments for AD patients at all stages of disease.
Key to achieving this goal is the identification of resources/infrastructure and multi-stakeholder partnerships necessary to successfully implement this research agenda and strategies to empower patients and engage citizens.
The 2018 Summit will bring together leading researchers, innovators and public advocates from academia, industry, the non-profit sector and NIH. The program will feature progress made toward achieving the National Plan’s research goal to Treat and Prevent Alzheimer’s by 2025, as well as a robust discussion on the continued transformation of the process of AD research and drug development into one that is participatory, collaborative, well-integrated and capable of delivering the cures that are so desperately needed.
For more information please visit
https://fnih.org/what-we-do/current-lectures-awards-and-events/adresearchsummit
